Muscular dystrophy is a muscle wasting ailment that has many diverse forms. Muscular dystrophies are a cluster of genetic ailments that affect skeletal muscles and often also heart muscle. The symptoms embrace muscle weakness and progressive muscle wasting. Duchenne muscular dystrophy (DMD) is the most common and a very severe kind of the disease. It is triggered by a hereditary fault which averts the production of a protein called dystrophin. Without dystrophin, muscles are delicate and are easily impaired. Over time, so much impairment builds up that the body can’t overhaul it and muscles waste away, causing progressive disability in patients.
Until recently, there was little hope that the extensive muscle degeneration that escorts this disease could be fought. However, stem cell therapy now offers that hope. Like other degenerative sicknesses, DMD is the consequence of loss of cells that are needed for accurate functioning of the body. In the case of DMD, a vital muscle protein is transmuted, and its absenteeism results in progressive degeneration of essentially all the muscles in the body. To start to approach a therapy for this condition, we must offer a new supply of stem cells that carry the absent protein that is lacking in DMD. These cells must be delivered to the body in such a way that they will engraft in the muscles and create new, healthy muscle tissue on a continuing basis. For more information on stem cell Treatment for Muscular Dystrophy in India, you can visit StemCellCareIndia.